Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Phase III Clinical Trial News Monitoring

Get by Email • RSS

Published on 09:28 GMT

Genetic cholesterol eliminated by new drug, reducing heart attack risk, study finds

Dr. Nick Norwitz, a study leader and independent researcher at the University of Oxford, discusses the surprising findings of a new study on the link between ketogenic diets and heart disease risk. Researchers have discovered an experimental medication …

Source: Fox News - Right-wing
Published on 05:24 GMT

Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris

Bausch Health, Canada Inc, part of Bausch Health Companies Inc announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Canadian public drug plan coverage for PrCABTREO (clindamycin phosphate, adapalene and …

Source: Pharmabiz.com - Neutral
Published on 05:59 GMT

The Chinese CEO who believes her cancer drug can beat Merck’s bestseller

It isn’t a $3 T-shirt or an electronic gadget. It is a cancer drug her company discovered—one that has made her the face of a rising pharmaceutical star. When Xia founded her company with three colleagues in 2012, China had few labs capable of finding …

Source: Mint - Neutral
Published on Apr 11, 2025

Alzheon’s Alzheimer’s pill fails in Phase III trial

US-based Alzheon’s Alzheimer’s disease pill has failed in a Phase III trial, but the biopharma still holds hope for the drug after seeing signals in a subgroup of patients. The company said that while valiltramiprosate did not meet the primary endpoint in …

Source: Clinical Trials Arena - Label Pending
Published on Apr 11, 2025

Agitated Solutions receives IND application clearance from US FDA to begin phase 3 clinical trial for its novel contrast ...

The US Food and Drug Administration (FDA) has cleared Agitated Solutions Incorporated (ASI)’s Investigational New Drug (IND) application for its novel contrast agent, ASI-02, enabling the initiation of its phase 3 clinical trial. This multi-center …

Source: Pharmabiz.com - Neutral
Published on Apr 10, 2025

Intas Pharmaceutical Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Fibrogen-I

New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct a Phase III clinical trial of Fibrogen-I (Human Fibrinogen Injection) for on-demand …

Source: Medical Dialogues - Uncategorized
Published on Apr 11, 2025

NICE recommends new combination breast cancer drug

The agency’s recommendation could provide eligible breast cancer patients with a treatment that analysis suggest is to likely to work as well as two medicines already recommended by NICE. The National Institute For Health and Care Excellence (NICE)’s has …

Source: European Pharmaceutical Review - Neutral
Published on Apr 11, 2025

AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use

AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, providing a new targeted therapy option that significantly increases progression-free survival (PFS) in breast cancer patients. …

Source: Pharmaceutical Technology - Neutral
Published on Apr 10, 2025

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on Apr 10, 2025

MHRA places UK as global leader of clinical trials once again

The UK Medicines and Healthcare products Regulatory Agency (MHRA) claims the UK is again a global leader in clinical trials. As part of the project, in collaboration with the University of Liverpool, the MHRA has published a paper in the British Journal of …

Source: Clinical Trials Arena - Label Pending
Published on Apr 11, 2025

New reports suggest diabetes weight loss drugs could reduce Alzheimer's risk

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as Ozempic and Wegovy), are now drawing increased attention for their potential to protect brain health. Two recent studies and an editorial …

Source: Medical Xpress - Neutral
Published on Apr 10, 2025

Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing secondary progressive multiple sclerosis (nrSPMS), where there …

Source: Pharmabiz.com - Neutral
Published on Apr 11, 2025

GC Biopharma gets Korean Ministry of Food and Drug Safety approval for BARYTHRAX, the world's first recombinant anthrax ...

GC Biopharma, formerly known as Green Cross Corporation is a biopharmaceutical company headquartered in Yong-in, announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, which is jointly developed by GC …

Source: Pharmabiz.com - Neutral
Published on 15:16 GMT

This Pharma Company Is Betting Big On A Chinese Ozempic Rival

Serial Salesman: Kailera CEO Ron Renaud has built and sold three biotechs, the last for $8.7 billion. “Companies get bought, they don’t get sold,” he says. But the obesity market’s frenzy could make Kailera a prime acquisition target. Albie Colantonio for …

Source: Forbes - Neutral
Published on Apr 11, 2025

Alzheon’s Precision Medicine Approach to Resurrect an Alzheimer’s Drug Fails Pivotal Study

An experimental Alzheimer’s disease therapy designed by Alzheon to reduce depositions of amyloid plaque in the brain failed to beat a placebo in a Phase 3 study, the latest blow to a drug whose history is marked by clinical trial shortfalls. The twice- …

Source: MedCity News - Neutral
Published on Apr 10, 2025

Oculis Completes Enrollment In Both DIAMOND Phase 3 Trials Of OCS-01 In Diabetic Macular Edema

(MENAFN- GlobeNewsWire - Nasdaq) ZUG, Switzerland, April 10, 2025 (GLOBE NEWSWIRE) -- DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or …

Source: MENAFN - Uncategorized
Published on Apr 9, 2025

Stroke Patients Discharged from Hospital Sooner when Administered Revalesio's RNS60; New Statistically Significant ...

Newswise — April 9, 2025 -- Revalesio, a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders, today announced new data from its completed Phase 2 RESCUE clinical trial of RNS60 in acute ischemic stroke …

Source: Newswise - Neutral
Published on Apr 9, 2025

Phase 3 Study to Test 1st Generation Antihistamine EPX-100 in Lennox-Gastaut Syndrome

A new phase 3 study (NCT05066217) will test the efficacy and safety of EPX-100 (Harmony Biosciences), a 1st generation antihistamine agent, as a potential treatment for patients with Lennox-Gastaut syndrome (LGS), a rare epileptic disorder. Overall, the …

Source: NeurologyLive - Label Pending
Published on Apr 10, 2025

Moffitt-led international study finds new drug delivery system effective against rare eye cancer

TAMPA, Fla. (Apr. 10, 2025) — A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease …

Source: EurekAlert! - Neutral

02 days 11:21:39

Featured Releases

Got News to Share? · Submit · See All

Published on April 12, 2025 - 13:30 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. ...

NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE: ATNM). Such investors are advised to contact Danielle Peyton at …

Distribution channels: Consumer Goods, Law ...
Published on April 11, 2025 - 11:23 GMT

India Spectacles Market Generated Opportunities, Future Scope 2025-2032 | Vetoquinol, NexGen Pharmaceuticals, Norbrook

BURLINGAME, CA, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- India Spectacles Market is estimated to be valued at USD 4.31 Bn in 2025 and is expected to reach USD 9.20 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 11, 2025 - 20:01 GMT

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on April 11, 2025 - 20:15 GMT

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 11, 2025 - 15:35 GMT

Nika Pharmaceuticals, Inc. (NIKA) Latest Developments

HENDERSON, Nev., April 11, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) published a report on the therapeutic effect and potential economic impact of ITV-1. The document contains the company’s findings on the effects of the drug on …

Distribution channels: Environment, Healthcare & Pharmaceuticals Industry ...
Published on April 11, 2025 - 20:00 GMT

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with ...

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. (“Actinium” …

Distribution channels: Consumer Goods, Law ...
Published on April 11, 2025 - 12:00 GMT

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2025 financial results on Thursday, May 8, 2025 after the market closes. Company management will host a …

Distribution channels:
Published on April 11, 2025 - 12:30 GMT

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and ...

Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the drug approaches 2027 exclusivity expiration, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 802,697,478 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on April 12, 2025 - 00:21 GMT

Physician launches dandRX™, an Anti-Dandruff Solution for Healthier, Flake-Free Scalps

PHILADELPHIA, PA, UNITED STATES, April 12, 2025 /⁨EINPresswire.com⁩/ -- A new anti-dandruff shampoo, developed by a practicing physician, is now available to consumers seeking science-backed scalp care. DandRx™, created by Dr. Deepak Khanna, is …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on April 11, 2025 - 23:05 GMT

Verona’s Pursue Physical Therapy & Performance Training Becomes Go-To Clinic for Pickleball Injury Care and Prevention

Pursue Physical Therapy & Performance Training in Verona emerges as the leading choice for pickleball injury treatment & prevention. VERONA, NJ, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- As pickleball’s popularity soars …

Distribution channels: Healthcare & Pharmaceuticals Industry, Sports, Fitness & Recreation ...
Published on April 11, 2025 - 22:41 GMT

Pursue Physical Therapy & Performance Training Helps Hoboken Save Time and Money with Direct Access Physical Therapy

Pursue PT in Hoboken demonstrates how NJ's Direct Access law empowers patients to receive faster care and lower healthcare expenses. HOBOKEN, NJ, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Pursue Physical Therapy & Performance …

Distribution channels: Healthcare & Pharmaceuticals Industry, Sports, Fitness & Recreation ...
Published on April 11, 2025 - 22:16 GMT

Pursue Physical Therapy & Performance Training of Cedar Knolls Debunks Common Physical Therapy Myths for NJ Residents

Pursue Physical Therapy & Performance Training in Cedar Knolls clarifies and debunks common myths about PT in New Jersey. CEDAR KNOLLS, NJ, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Pursue Physical Therapy & Performance …

Distribution channels: Healthcare & Pharmaceuticals Industry, Sports, Fitness & Recreation ...
Published on April 11, 2025 - 22:10 GMT

Verici Receives Medicare Coverage for Tutivia

Verici Dx Plc (LSE:VRCI) FRANKLIN, TN, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant is pleased to announce a positive Technical Assessment by …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 11, 2025 - 21:31 GMT

Positive Approach to Care Selected for National PSA Campaign on Dementia Care by World Impact Productions

Positive Approach to Care® is a leading organization in dementia care education founded by internationally recognized dementia care educator Teepa Snow. MIAMI, FL, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Positive Approach to Care® is …

Distribution channels: Beauty & Hair Care, Conferences & Trade Fairs ...
Published on April 11, 2025 - 21:06 GMT

María José Jirón-Bendaña Recognized as High-Performing Committee Member by INTA's Leadership Development Committee

MANAGUA, NICARAGUA, April 11, 2025 /⁨EINPresswire.com⁩/ -- Bendaña & Bendaña, one of Central America’s leading Intellectual Property (IP) firms, is proud to announce that María José Jirón-Bendaña, partner attorney at the firm, has been …

Distribution channels: Conferences & Trade Fairs, Consumer Goods ...
Published on April 11, 2025 - 19:36 GMT

Ageless Aesthetics Celebrates Multiple Wins at the 2025 Aesthetic Everything® Awards

Ageless Aesthetics Celebrates Multiple Wins at the 2025 Aesthetic Everything® Awards INDIANAPOLIS, IN, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Ageless Aesthetics, a leading medical spa in Indianapolis, is thrilled to announce their …

Distribution channels: Beauty & Hair Care, Companies ...
Published on April 11, 2025 - 19:18 GMT

CodeEMR's Medical Coding Reimbursement Solutions to be Presented at MGMA Focus Conference, April 13-15 (Booth #212)

WOBURN, MA, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- CodeEMR, a leading provider of remote medical coding and auditing services for medical practices, hospitals, and health systems, will present its full range of healthcare coding solutions …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on April 12, 2025 - 06:57 GMT

PrimeBiome— How PrimeBiome Gummies Boost Glowing Skin With Bacillus Coagulans & Babchi

ST. PETERSBURG, Fla., April 12, 2025 (GLOBE NEWSWIRE) -- In today's highly competitive landscape of health and wellness supplements, consumers are increasingly drawn to products backed by solid science and real-world results. PrimeBiome, a natural …

Distribution channels:
Published on April 12, 2025 - 06:40 GMT

Lipozem Reviews (BUYER ALERT!) Is It Legit And Safe To Use? Consumer Report On Reddit Breaks It Down!

MIAMI, April 12, 2025 (GLOBE NEWSWIRE) -- The Lipozem weight loss supplement has been garnering attention in the weight loss supplement market for quite some time. People are wondering what this hype is about, and this Lipozem review is going to reveal the …

Distribution channels:
Published on April 12, 2025 - 06:33 GMT

CMS proposes 2.8% payment update for SNFs

The Centers for Medicare & Medicaid Services April 11 issued a proposed rule for the skilled nursing facility prospective payment system for fiscal year 2026. The proposal would increase aggregate payments by 2.8%, which reflects a 3.0% market basket …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 12, 2025 - 06:33 GMT

Inpatient psychiatric facilities rule would increase payments by 2.4%

The Centers for Medicare & Medicaid Services April 11 issued a proposed rule for the inpatient psychiatric facility prospective payment system for fiscal year 2026. CMS proposes to increase IPF payments by a net 2.4%, equivalent to $70 million, in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 12, 2025 - 06:33 GMT

CMS proposes 2.6% payment update for IRFs

The Centers for Medicare & Medicaid Services April 11 released the fiscal year 2026 proposed rule for inpatient rehabilitation facilities. The rule would increase payments by 2.6% overall, which includes a 3.4% market basket update reduced by a 0.8 …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 12, 2025 - 06:33 GMT

CMS releases FY 2026 proposed rule for long-term care hospitals

The Centers for Medicare & Medicaid Services April 11 proposed increasing the long-term care hospital standard rate payments by 2.2% in fiscal year 2026 relative to FY 2025. This includes a 3.4% market basket update reduced by a 0.8 percentage point …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 12, 2025 - 06:33 GMT

CMS issues hospital IPPS proposed rule for FY 2026

The Centers for Medicare & Medicaid Services April 11 issued a proposed rule that would increase Medicare inpatient prospective payment system rates by a net 2.4% in fiscal year 2026, compared with FY 2025, for hospitals that are meaningful users of …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 11, 2025 - 18:12 GMT

DiaGen Ai Inc Announces its Selection as Top 100 Canadian Tech Company as Part of Scale Ai’s Delegation at VivaTech 2025

DiaGen Ai Inc. Announces its Selection as a Top 100 Canadian Tech Company VANCOUVER, BC, CANADA, April 11, 2025 /⁨EINPresswire.com⁩/ -- DiaGen Ai Inc. Announces its Selection as a Top 100 Canadian Tech Company as Part of Scale Ai’s Delegation at …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on April 11, 2025 - 17:51 GMT

Proactive MD Expands National Value-Based Network with Physical Therapy and Behavioral Health Services  

Locations in Maryland and New Hampshire to expand employer healthcare services BALTIMORE, MD, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Proactive MD®, one of the nation’s largest value-based care companies, announced the acquisition …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on April 11, 2025 - 17:04 GMT

Functional Medicine Doctors Now Available in Manhattan at Patients Medical PC

Patients Medical, an integrative and functional medicine clinic in Manhattan, offers root-cause-focused care that blends conventional and holistic treatments. NEW YORK, NY, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Functional Medicine …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on April 11, 2025 - 17:00 GMT

Millin Anchors Three New Contracts with Social Care Networks, Expanding Reach in Key Market

Millin expands NY reach, partnering with 3 SCNs (Healthy Alliance, WNYICC, Public Health Solutions) via RCM. LYNBROOK, NY, UNITED STATES, April 11, 2025 /⁨EINPresswire.com⁩/ -- Millin, a leading provider of Revenue Cycle Management (RCM) solutions …

Distribution channels: Business & Economy, Companies ...